Evidence map›Paper›PMID 26693425›Full record

ReviewIndian journal of endocrinology and metabolism

Telemedicine for diabetes care: An Indian perspective - feasibility and efficacy.

Jothydev Kesavadev, Banshi Saboo, Arun Shankar, Gopika Krishnan, Sunitha Jothydev

Open access · diamondAbstract readReview
In one paragraph

Review in Indian journal of endocrinology and metabolism. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 1 pooled it
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 1 synthesis or guideline pooled it, 41 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Challenges of Implementing Telemedicine Technology: A systematized Review.International journal of preventive medicine · 2024
    Review
  4. Article
  5. Review
  6. Review
  7. Digital health and diabetes: experience from India.Therapeutic advances in endocrinology and metabolism · 2021
    Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Jothydev KesavadevDepartment of Diabetes, Jothydev's Diabetes Research Centre, Trivandrum, Kerala, India.
Banshi SabooDepartment of Diabetes, Diacon Hospital, Ahmedabad, Gujarat, India.
Arun ShankarDepartment of Diabetes, Jothydev's Diabetes Research Centre, Trivandrum, Kerala, India.
Gopika KrishnanDepartment of Diabetes, Jothydev's Diabetes Research Centre, Trivandrum, Kerala, India.
Sunitha JothydevDepartment of Diabetes, Jothydev's Diabetes Research Centre, Trivandrum, Kerala, India.
Diacon Hospital · INJothydev's Diabetes and Research Center · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Diabetes is a chronic and costly disease. In India, the usual practice among patients is to visit the doctor once in every 2-3 months to get advice on changes in the dosages of medications. The Diabetes Tele Management System (DTMS(®)) is a telemedicine based follow-up program originally introduced at Jothydev's Diabetes Research Centre at Trivandrum South India in 1998. It is a chronic disease management system which enables patient to interact lively with a professionally trained multidisciplinary team comprising of diabetes educators, nurses, dieticians, pharmacists, psychologists, physicians, etc., in modifying the dosages of medications, diet, and physical activity either through telephone/email/secure website. The uniquely designed software and the trained multidisciplinary team overcomes the globally recognized major barriers to diabetes management namely fear of hypoglycemia, polypharmacy, discontinuation of stains, and antihypertensives or wrong injection techniques. DTMS is designed to provide individualized therapy advices on glycosylated hemoglobin, blood pressure, and low density lipoprotein customized to multiple patient characteristics which help attain goals of therapy. The system has been tested on various platforms over a decade and was shown to be a patient friendly approach with successful outcomes due to a live "round-the-clock" interactive communication in contrast to text or recorded messages. The major challenge to the widespread use of DTMS(®) is seeking a source of funding this unique telemedicine program.

Indexed as

Cost-effectivenessdiabetesfollow-uphypoglycemiatechnologytelemedicine

Identifiers

PMID26693425
PMCPMC4673803
OpenAlexW2146998236

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.